Jieqiong Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jieqiong Zhou has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Danelle Rolle-McFarland
School of Health Sciences, Purdue University, West Lafayette, IN, USA
1 shared publication - Ellen M. Wells
School of Health Sciences, Purdue University, West Lafayette, USA
1 shared publication - Farshad Mostafaei
Radiation Oncology, Medical College of Wisconsin, Milwaukee, USA
1 shared publication - Linda Huiling Nie
School of Health Sciences, Purdue University, West Lafayette, IN 47907, USA
1 shared publication - Qiyuan Fan
National Engineering Research Center for Big Data Technology and System, Services Computing Technology and System Lab, Hubei Engineering Research Center on Big Data Security, Hubei Key Laboratory of Distributed System Security, Jinyinhu Laboratory, School of Cyber Science and Engineering, Huazhong University of Science and Technology, Wuhan, China
1 shared publication - Wei Zheng
School of Health Sciences, Purdue University, West Lafayette, USA
1 shared publication
Latest Publications
- Open Access
- 26 June 2018
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 15 (7) , 1341
Development of a Cumulative Exposure Index (CEI) for Manganese and Comparison with Bone Manganese and Other Biomarkers of Manganese Exposure
Manganese (Mn) exposure can result in parkinsonism. However, understanding of manganese neurotoxicity has been limited by the lack of a cumulative Mn biomarker. Therefore, the current goal was to develop Mn cumulative exposure indices (MnCEI), an established method to estimate cumulative exposure, and determine associations of MnCEI with blood Mn (BMn), fingernail Mn (FMn), and bone Mn (BnMn). We completed a cross-sectional study of 60 male Chinese workers. Self-reported occupational history was used to create two MnCEIs reflecting the previous 16 years (MnCEI16) and total work history (MnCEITOT). An in vivo neutron activation analysis system was used to quantify BnMn. BMn and FMn were measured using ICP-MS. Mean (standard deviation) MnCEITOT and MnCEI16 were 37.5 (22.0) and 25.0 (11.3), respectively. Median (interquartile range) BMn, FMn, and BnMn were 14.1 (4.0) μg/L, 13.5 (58.5) μg/g, and 2.6 (7.2) μg/g dry bone, respectively. MnCEI16 was significantly correlated with FMn (Spearman’s ρ = 0.44; p = 0.02), BnMn (ρ = 0.44; p < 0.01), and MnCEITOT (ρ = 0.44; p < 0.01). In adjusted regression models, MnCEI16 was significantly associated with BnMn (β = 0.03; 95% confidence interval = 0.001, 0.05); no other biomarkers were associated with MnCEI. This suggests BnMn may be a useful biomarker of the previous 16 years of Mn exposure, but larger studies are recommended.
- 26 June 2018
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 15 (7) , 1341
Open AccessDevelopment of a Cumulative Exposure Index (CEI) for Manganese and Comparison with Bone Manganese and Other Biomarkers of Manganese Exposure
Manganese (Mn) exposure can result in parkinsonism. However, understanding of manganese neurotoxicity has been limited by the lack of a cumulative Mn biomarker. Therefore, the current goal was to develop Mn cumulative exposure indices (MnCEI), an established method to estimate cumulative exposure, and determine associations of MnCEI with blood Mn (BMn), fingernail Mn (FMn), and bone Mn (BnMn). We completed a cross-sectional study of 60 male Chinese workers. Self-reported occupational history was used to create two MnCEIs reflecting the previous 16 years (MnCEI16) and total work history (MnCEITOT). An in vivo neutron activation analysis system was used to quantify BnMn. BMn and FMn were measured using ICP-MS. Mean (standard deviation) MnCEITOT and MnCEI16 were 37.5 (22.0) and 25.0 (11.3), respectively. Median (interquartile range) BMn, FMn, and BnMn were 14.1 (4.0) μg/L, 13.5 (58.5) μg/g, and 2.6 (7.2) μg/g dry bone, respectively. MnCEI16 was significantly correlated with FMn (Spearman’s ρ = 0.44; p = 0.02), BnMn (ρ = 0.44; p < 0.01), and MnCEITOT (ρ = 0.44; p < 0.01). In adjusted regression models, MnCEI16 was significantly associated with BnMn (β = 0.03; 95% confidence interval = 0.001, 0.05); no other biomarkers were associated with MnCEI. This suggests BnMn may be a useful biomarker of the previous 16 years of Mn exposure, but larger studies are recommended.